title: Progesterone metabolites, "xenobiotic-sensing" nuclear receptors, and the metabolism of maternal steroids.
abstract: During development, embryos utilize steroid signals to direct sexual differentiation of tissues necessary for reproduction. Disruption of these signals by exogenous substances (both natural and synthetic) frequently produce phenotypic effects that can persist into adulthood and influence reproduction. This paper reviews the evidence that during embryonic development, progesterone metabolites and xenobiotic-sensing nuclear receptors may interact to increase the expression of numerous enzymes responsible for steroid metabolism in oviparous and placental amniotes. In these groups, embryonic development is characterized by (1) elevated progesterone concentrations, (2) 5 beta reduction being the primary metabolic pathway of progesterone, (3) the presence of xenobiotic-sensing nuclear receptors that can bind 5 beta metabolites of progesterone, and (4) increased expression of a suite of enzymes responsible for the metabolism of multiple steroids. We propose that xenobiotic-sensing nuclear receptors initially evolved to buffer the developing embryo from the potentially adverse effects of various maternal steroids on sexual differentiation.
authors.affiliation: School of Biological Sciences, Campus Box 4120, Illinois State University, Normal, IL 61790-4120, USA. rpaitz@ilstu.edu
authors.forename: Ryan T
authors.initials: RT
authors.lastname: Paitz
authors.forename: Rachel M
authors.initials: RM
authors.lastname: Bowden
mesh_terms: D000818:Animals; D047108:Embryonic Development; D005260:Female; D006801:Humans; D008297:Male; D010088:Oxidoreductases / Q000378:metabolism; D010920:Placenta / Q000201:enzymology; D011247:Pregnancy; D011374:Progesterone / Q000378:metabolism*; D018160:Receptors, Cytoplasmic and Nuclear / Q000378:metabolism*; D012733:Sex Differentiation; D015398:Signal Transduction; D013256:Steroids / Q000378:metabolism*; D015262:Xenobiotics / Q000378:metabolism
chemical_list: D018160:Receptors, Cytoplasmic and Nuclear; D013256:Steroids; D015262:Xenobiotics; D011374:Progesterone; D010088:Oxidoreductases; C021936:3-oxo-5 beta-steroid delta 4-dehydrogenase